There is compelling evidence that growth factors regulate both cell proliferation and differentiation, but little is known about the mechanisms that regulate growth factor production. The fibroblast growth factor k-FGF is one of the first growth factors to be produced during mammalian development and it is produced by a wide range of tumors. Recently, embryonal carcinoma (EC) cells have been used to study the expression and regulation of the k-FGF oncogene. EC cells, which serve as an excellent model system for studying early development, have been shown to produce k-FGF; whereas their differentiated cells do not. Efforts to understand how k-FGF expression is regulated indicate that differentiation represses transcription of this gene. This conclusion is supported by nuclear run-off studies and by the differential expression of promoter/reporter gene constructs in EC cells and their differentiated cells. Based on the most recent studies in the PI's laboratory, it is hypothesized that expression of the k-FGF gene in EC cells and their differentiated cells is controlled by at least three cis-regulatory elements: an essential enhancer in the third exon of the gene, a positive cis-regulatory element and a negative cis-regulatory element located upstream of the transcription start site. To test this hypothesis and to determine how expression of this gene is regulated, four Specific Aims are proposed: 1) Identify and map precisely the location of cis-regulatory elements that control expression of the k-FGF gene in mouse EC cells and their differentiated cells. 2) Examine the binding of nuclear proteins to the cis-regulatory elements that control expression of the k-FGF gene. 3) Identify the transcription factors that regulate expression of this gene. 4) Determine how differentiation of EC cells regulates expression of the transcription factors that regulate expression of the k-FGF gene. The work proposed in this application will address a critical gap in our current knowledge, namely, our limited understanding of the mechanisms by which growth factor production is regulated. Equally important, this work will help advance our understanding of how differentiation regulates the expression of transcription factors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA074771-14
Application #
6124556
Study Section
Human Embryology and Development Subcommittee 1 (HED)
Program Officer
Mietz, Judy
Project Start
1985-08-01
Project End
2000-11-30
Budget Start
1999-12-01
Budget End
2000-11-30
Support Year
14
Fiscal Year
2000
Total Cost
$203,524
Indirect Cost
Name
University of Nebraska Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Omaha
State
NE
Country
United States
Zip Code
68198
Cox, Jesse L; Wilder, Phillip J; Wuebben, Erin L et al. (2014) Context-dependent function of the deubiquitinating enzyme USP9X in pancreatic ductal adenocarcinoma. Cancer Biol Ther 15:1042-52
Ormsbee Golden, Briana D; Wuebben, Erin L; Rizzino, Angie (2013) Sox2 expression is regulated by a negative feedback loop in embryonic stem cells that involves AKT signaling and FoxO1. PLoS One 8:e76345
Mallanna, Sunil K; Ormsbee, Briana D; Iacovino, Michelina et al. (2010) Proteomic analysis of Sox2-associated proteins during early stages of mouse embryonic stem cell differentiation identifies Sox21 as a novel regulator of stem cell fate. Stem Cells 28:1715-27
Boer, Brian; Bernadt, Cory T; Desler, Michelle et al. (2006) Differential activity of the FGF-4 enhancer in F9 and P19 embryonal carcinoma cells. J Cell Physiol 208:97-108
Boer, Brian; Luster, Troy A; Bernadt, Cory et al. (2005) Distal enhancer of the mouse FGF-4 gene and its human counterpart exhibit differential activity: critical role of a GT box. Mol Reprod Dev 71:263-74
Bernadt, Cory T; Nowling, Tamara; Wiebe, Matthew S et al. (2005) NF-Y behaves as a bifunctional transcription factor that can stimulate or repress the FGF-4 promoter in an enhancer-dependent manner. Gene Expr 12:193-212
Hou, Jingwen; Wilder, Phillip J; Bernadt, Cory T et al. (2004) Transcriptional regulation of the murine Elf3 gene in embryonal carcinoma cells and their differentiated counterparts: requirement for a novel upstream regulatory region. Gene 340:123-31
Kopp, Janel L; Wilder, Phillip J; Desler, Michelle et al. (2004) Unique and selective effects of five Ets family members, Elf3, Ets1, Ets2, PEA3, and PU.1, on the promoter of the type II transforming growth factor-beta receptor gene. J Biol Chem 279:19407-20
Bernadt, Cory T; Nowling, Tamara; Rizzino, Angie (2004) Transcription factor Sox-2 inhibits co-activator stimulated transcription. Mol Reprod Dev 69:260-7
Nowling, Tamara; Bernadt, Cory; Johnson, Lance et al. (2003) The co-activator p300 associates physically with and can mediate the action of the distal enhancer of the FGF-4 gene. J Biol Chem 278:13696-705

Showing the most recent 10 out of 30 publications